The PPLD has advantages over conventional regression methods in application to moderately sized genome-wide
Veronica J Vieland1,2,3, Sang-Cheol Seok1
1Battelle Center for Mathematical Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States of America.
Plos One
|September 22, 2021
Summary
This study introduces a new statistical method, the time-to-event PPLD, for analyzing genetic data in rare diseases like Duchenne Muscular Dystrophy. Simulations show it performs well in small sample sizes, offering advantages over traditional methods.
Area of Science:
- Genetics
- Statistical Genetics
- Bioinformatics
Background:
- Genome-Wide Association Studies (GWAS) typically require large sample sizes.
- Rare diseases, such as Duchenne Muscular Dystrophy (DMD), present challenges due to limited patient cohorts.
- Existing GWAS methods may not be optimal for small sample sizes common in rare disease research.
Purpose of the Study:
- To evaluate the performance of the time-to-event PPLD (TE-PPLD) statistic in small to moderate sample sizes.
- To compare the efficacy of TE-PPLD against Cox Proportional Hazards analysis for time-to-event phenotypes in GWAS.
- To inform the ongoing GWAS for genetic modifiers of Duchenne Muscular Dystrophy.
Main Methods:
- Development and adaptation of the PPLD statistic for time-to-event phenotypes (TE-PPLD).
- Simulation studies to explore the behavior of TE-PPLD under various small sample size scenarios.
- Comparative analysis of TE-PPLD and Cox Proportional Hazards models.
Main Results:
- The TE-PPLD demonstrates robust performance in simulations involving small to moderate sample sizes.
- TE-PPLD shows advantages over Cox Proportional Hazards analysis in specific contexts relevant to rare disease GWAS.
- Simulation results provide guidance for the application of TE-PPLD in the DMD genetic modifier study.
Conclusions:
- The TE-PPLD is a promising statistical approach for GWAS of time-to-event phenotypes in rare diseases.
- TE-PPLD offers a viable alternative to traditional regression-based GWAS methods when sample sizes are limited.
- This method enhances the feasibility of conducting genetic association studies for rare Mendelian disorders.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
14.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.7K
01:12Analysis of Population Pharmacokinetic Data
448
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
448